Abstract digital waveforms in blue and purple

FDA Drug information

Vyvanse

Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)

Vyvanse LISDEXAMFETAMINE DIMESYLATE 10 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 10 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 10 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 10 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 20 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 20 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 20 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 20 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 30 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 30 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 30 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 30 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 40 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 40 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 40 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 40 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 50 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 50 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 50 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 50 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 60 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 60 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 60 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 60 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 70 mg/1 Takeda Pharmaceuticals America, Inc.
Vyvanse LISDEXAMFETAMINE DIMESYLATE 70 mg/1 Takeda Pharmaceuticals America, Inc.

Learning Zones

8 year old child with redness and peeling of the skin on the body.

Overview

Atopic Dermatitis in Paediatric Patients

1 mins

Unrecognizable female doctor holding graphic virtual visualization model of Lungs organ in hands. Multiple medical icons on the background.

Learning Zone

Type 2 Inflammation in COPD

1 mins

Learning Zone

Advances in Lymphoma

1 mins

UCB EHSF 2024 teaser tile image of 'medical summit'

Learning Zone

Advances in HS

30 mins

Learning Zone

All Things Angioedema and Urticaria: Podcasts

30 mins

3d rendered medically accurate illustration of a womans large intestine

Learning Zone

Ulcerative colitis Learning Zone

90 mins

Learning Zone

Psoriasis Academy

910 mins

Learning Zone

Alopecia areata Learning Zone

60 mins

Learning Zone

mCRPC in focus

1 mins

Pediatric Eosinophilic Esophagitis teaser image

Learning Zone

Type 2 Inflammation in Gastroenterology

160 mins

Myocardium Cardiac muscle fibers banner image

Learning Zone

Pompe Disease: Key findings from WMS 2022

150 mins

Doctor holding patients hand in consultation

Learning Zone

Supportive care in oncology Learning Zone

150 mins

Learning Zone

Albumin in fluid management

115 mins

Image of AI generated blood clot formation that would require pharmacological treatments available for various vascular conditions, such as anticoagulants, anti platelet agents, and vasodilators

Learning Zone

Antiplatelet therapy in ACS: Choices and Controversies

270 mins

patient receiving dialysis, hospital image

Learning Zone

Chronic Kidney Disease Learning Zone

340 mins

Learning Zone

Inflammatory Bowel Disease Learning Zone

100 mins

Learning Zone

CDK4/6 inhibitors in breast cancer

199 mins

Learning Zone

Fibrinogen Deficiency in Bleeding Learning Zone

160 mins

Learning Zone

Oral Anticoagulation Reversal Learning Zone

355 mins

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.